Dr. Natasha Robinette, a neurological radiologist at Karmanos Cancer Institute, knows first-hand how confusing it can be to navigate the complex world of cancer treatment after a new diagnosis, as she ...

For individuals facing glioma, understanding the nature of tumor recurrence is important for managing expectations and making informed treatment decisions. Despite common terminology suggesting tumors ...

Fatigue is one of the most universal side effects experienced by patients undergoing glioma treatment, particularly those on extended regimens combining radiation with chemotherapy. This exhaustion ...

Glioblastoma is the most aggressive form of primary brain tumor. It is classified as a grade 4 glioma and presents significant treatment challenges due to its highly invasive nature, rapid growth, and ...

A clinical trial is a research study involving eligible volunteers that looks into using new drugs or therapies. The goal of ...

For patients with metastatic colon cancer, next-generation sequencing has become an essential tool in determining personalized treatment approaches. This molecular testing examines genes to identify ...

A class of drugs used to treat type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1RAs), have become a popular tool to help with weight loss. Explore common topics related to GLP-1RAs: ...

Veteran comedian Jay Leno, 74, is enjoying life as his wife Mavis’ conservator during her struggle with “advanced dementia,” and we’re delighted to see the iconicTV host embracing life as a caregiver ...

Haylee Busby, a 20-year-old dispatcher in Carson City, Nevada, was diagnosed with a rare and aggressive form of liver cancer called Fibrolamellar carcinoma (FLC) after experiencing “severe weakness in ...

A type of CAR T-cell therapy known as lisocabtagene maraleucel (often called Liso-Cel) is showing real promise in treating patients with diffuse large B-cell lymphoma that has either returned or not ...

CAR T-cell therapy offers the possibility of long-term remission, even cure, for patients whose lymphoma resisted other treatments or has returned shortly after initial treatment. When a patient ...